top of page



  • Nagarajan S, Rao SV*, Sutton J*, Cheeseman D*, Dunn S, Papachristou EK, Prada J-EG, Couturier D-L, Kumar S, Kishore K, Chilamakuri CSR, Glont S-E, Archer Goode E, Brodie C, Guppy N, Natrajan R, Bruna A, Caldas C, Russell A, Siersbæk R, Yusa K, Chernukhin I, Carroll JS, ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response

        Nature Genetics, 2020, 52, 187–197        

  • Jozwik KM, Chernukhin I, Serandour AA, Nagarajan S#, Carroll JS#, FOXA1 directs H3K4 monomethylation at enhancers via recruitment of the methyltransferase MLL3  Cell Reports, 2016, 17 (10), 2715–2723                          

       # Co-corresponding author 


Read More


  • Farcas AM, Nagarajan S, Cosulich S, Carroll JS, Genome-wide estrogen receptor activity in breast cancer, Endocrinology , 2021, 162:2, 1-15

  • Hossan T, Kundu S, Alam SS and Nagarajan S, Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus,  Endocrine, Metabolic & Immune Disorders-Drug Targets, Review, 2019, 19 (6), 775-786

Read More

Book chapters

  • Jones J, Zecchini H and Nagarajan S, Multiplexed detection and analysis of low abundant abundance long non-coding RNA using RNAscope® in cultured cells, Methods in Molecular Biology, In Situ Hybridization Protocols, Springer Protocols, 2020, 2148, 111-125

  • Nagarajan S and Johnsen SA, “Crosstalk between Histone Modifications Integrates Various Signaling Inputs to Fine-Tune Transcriptional Output”, Chromatin Signaling and Diseases, 2016, Elsevier

Read More
bottom of page